ZE
Zealand Pharma
ZEAL·NASDAQCopenhagen DKFounded 1998600 employees
Mid CapbiotechPublicMetabolicRare Disease
Platform: Peptide
Market Cap
$6B
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (ZEAL)
Loading ZEAL stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ZEA-9089 | ZEA-9089 | Phase 2/3 | 2 | Menin | Melanoma | ||
| Lisoosocimab | ZEA-2231 | Approved | 3 | KIF18A | EoE | ||
| Semalucimab | ZEA-1183 | Phase 3 | 2 | BET | DMD | ||
| Talazumab | ZEA-3974 | Phase 1/2 | 1 | WEE1 | ASPancreatic Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (7)